TMCnet News
Research and Markets: Cancer Molecular Diagnostics: Market Developments, Growth Areas and Opportunities 2014-2017DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/lhbqrm/cancer_molecular) has announced the addition of the "Cancer Molecular Diagnostics: Market Developments, Growth Areas and Opportunities 2014" report to their offering. Cancer diagnostics is one of the most dynamic medical fields, reflecting efforts to translate new advances in cancer into improved tests and treatments. Increasingly, researchers and clinicians pursue common goals towards more personalised therapies, resulting in greater market complexity, new research and clinical needs and changes in laboratory practices. At the same time, end-users seek more powerful tests and instrumentation, as well as greater versatility and flexibility, to meet their increasingly diverse testing needs. This report presents the findings from a new market study of cancer molecular diagnostics and provides valuable commercial insights to suppliers in this field. The challenges of esablishing more powerful cancer diagnostics demand that suppliers and end-users work closely to translate new advances into tests that impact on clinical care. These challenges reflect the complexity of this disease and the needs of end-users to make the most of available technology and understanding, to introduce improved capabilities in their own specialised areas. Forging closer relationship with end-users is therefore essential to driving innovation in this field, and to recognising new opportunities. Biopharm Reports assists suppliers in these key areas. Cancer Molecular Diagnostics 2014 involved the participation of 596 experienced clinicians and research scientists and profiled current practices, developments, trends and future plans over the next three years, as well as growth, shrinkage and opportunities across key areas of this market. Its findings provide suppliers with a wealth of market information on the current and evolving use of cancer molecular diagnostics. Key Topics Covered: 1. Introduction 2. Study Participants 3. Cancer Types 4. Cancer Diagnostic Techniques 5. Molecule Types 6. Study Samples 7. Circulating Tumour Cells 8. Cancer Stem Cells 9. Molecular Cancer Diagnostic Techniques 10. Cancers Tested using Molecular Diagnostic Techniques 11. Molecular Forms 12. Cancer Molecular Diagnostics Biomarkers 13. Clinical Utilities of Cancer Molecular Biomarkers 14. Multiplex Methods 15. Molecular Cancer Diagnostics Trends 16. Main Suppliers 17. Advantages and Disadvantages of Molecular Cancer Diagnostics 18. Future requirements in Cancer Molecular Diagnostics 19. Replacement of Non-Molecular Cancer Diagnostics 20. Automation in Cancer Molecular Diagnostics 21. Most Tested Cancers 22. Costs of Molecular Diagnostics 23. Discussion For more information visit http://www.researchandmarkets.com/research/lhbqrm/cancer_molecular
|